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Standard production processes for antimicrobial peptides (amps) comprise of batch cultivations in upstream and 
chromatographic purification in down-stream. Although chromatography in most variations is limited in scale-up 
and one of the most expensive steps in the production chain it still remains the industrial gold standard in 
downstream processing. To overcome this bottleneck in the production chain, alternative column-free 
purification strategies with aggregating tags are a promising approach. Such a process can be automated and 
scaled-up in consent with reasonable expenses. However, new processes involving alternative downstream 
strategies have to be developed starting from scratch. In regards to vector design it must be considered whether 
the product is intended to be expressed in a soluble or insoluble form, in which cell compartment it shall be 
synthesized or what kind of plasmid features are needed for the realization of an automated downstream 
process. In this study the soluble production of an amp with several structural disulfide bonds was conducted in 
an E. coli strain with an oxidizing cytoplasm. To generate the expression vector a unique combination of plasmid 
features was assembled by Golden Gate cloning to enable an automated downstream procedure with 
aggregating tags for column-free purification. The junction of a thioredoxin-tag (trxA) with elastin-like-
polypeptides (ELPs) and self-splicing inteins allows the release of the protein from the cytoplasm into the 
extracellular space and the separation from host cell proteins (HCP) in the bioreactor vessel. The trxA-tag acts 
as a solubility enhancer to the product and facilitates the release into the extracellular space via simple osmotic 
shock procedure. Reversible, temperature dependent phase transition of the ELPs enables purification of the 
desired product from impurities such as HCP and, after cleavage by self-splicing inteins, to separate the amp 





Figure 1 - Workflow of downstream processing using an ELP-thioredoxin-intein-amp construct for purification 
This interaction of thioredoxin-, ELP- and intein-tag facilitates scalability and economic feasibility with rendering 
cell disruption apparatuses, chromatographic columns and enzymatic digestion obsolete. In addition to the 
alternative downstream strategy, the integration of process analytical technology (PAT) in the upstream process 
and the implementation of a defined media generates a production process with high potential for application in 
pharmaceutical industry in regard of GMP-compliance. The presented bioprocess for amp production addresses 
crucial requirements for process automation in the up- and downstream sector and promotes alternative 
strategies in process design. 
 
